Civica to Build an Essential Medicines Manufacturing Facility in Virginia
“This Virginia plant and our future employees there will play an instrumental role in preventing the chronic drug shortages that have interrupted hospital operations and put patients at risk for over a decade.”
National Drug Shortage Crisis Hits COVID Vaccine Rollout
Civica Rx’s business model is designed to alleviate manufacturing and supply chain problems, and in the process curtail generic drug shortages.
Groundbreaking in Petersburg, Virginia
Civica’s leadership team joined CEO Martin VanTrieste for a milestone groundbreaking celebration.
Partner AMPAC to Expand Near Civica Manufacturing Site
Virginia Governor Ralph Northam announced AMPAC Fine Chemical’s plans to expand, bringing new investment and jobs to Petersburg. Civica CEO Martin VanTrieste congratulated AMPAC and expressed his optimism about the end-to-end manufacturing partnership with AMPAC, Phlow, and Medicines for All Institute.
Martin VanTrieste on Retail Drugs
Managed Healthcare Executive spoke to Civica CEO Martin VanTrieste about Civica’s tactics, strategies, and launch of an outpatient retail operating unit. Hear from Martin in a three-part video series from the discussion.
CivicaScript to Serve Patients in Retail Markets
New health plan partner, new president, new drug manufacturing partner
CivicaScript is the name for Civica’s operating unit dedicated to lowering the cost of select high-cost generic medicines. One of the nation’s largest health insurers and a leading drug manufacturer have joined the initiative.
The Health Care Utility Model: A Novel Approach to Doing Business
Catalyst, the NEJM platform to share innovative ideas and practical applications for enhancing the value of health care delivery, writes, “Leaders at Civica Rx have developed a potentially disruptive health care business model that enables private-sector efficiency and public-sector societal equity at scale.”
Groups Make Own Drugs to Fight High Drug Prices, Shortages
“Civica Rx was started three years ago by a hospital consortium. It now provides over 50 generic injectable medicines in chronic shortage to more than 1,400 hospital members and the Veterans Affairs and Defense departments. It already has sold enough medication to treat 17 million people, including many hospitalized with COVID-19. Now it’s expanding to help patients directly.”